Detalhe da pesquisa
1.
TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
Proc Natl Acad Sci U S A
; 121(18): e2320421121, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662551
2.
Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study.
Blood
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701426
3.
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.
Blood
; 142(6): 561-573, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084389
4.
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.
Blood
; 141(20): 2493-2507, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302166
5.
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Clin Chem
; 70(1): 273-284, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175592
6.
Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
Proc Natl Acad Sci U S A
; 118(41)2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615710
7.
Mutational landscape of gray zone lymphoma.
Blood
; 137(13): 1765-1776, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961552
8.
Characterization of DLBCL with a PMBL gene expression signature.
Blood
; 138(2): 136-148, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684939
9.
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.
Blood
; 137(16): 2196-2208, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33120427
10.
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
Br J Haematol
; 196(1): 116-126, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520052
11.
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.
Blood
; 134(18): 1528-1532, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527075
12.
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
Blood
; 134(10): 802-813, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292115
13.
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.
Blood
; 131(18): 2060-2064, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475959
14.
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.
Blood
; 131(18): 2036-2046, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467182
15.
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.
Blood
; 129(20): 2760-2770, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351934
16.
Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas.
Blood
; 128(9): 1206-13, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27268263
17.
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Blood
; 127(18): 2182-8, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26834242
18.
Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma.
Blood
; 137(9): 1256-1259, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967007
19.
Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.
Blood
; 125(6): 999-1005, 2015 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468570
20.
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup.
Blood
; 125(6): 959-66, 2015 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395426